Exposure–response analyses of abiraterone and its metabolites in real-world patients with metastatic castration-resistant prostate cancer

Prostate Cancer and Prostatic Diseases, Published online: 14 October 2019; doi:10.1038/s41391-019-0179-5Exposure–response analyses of abiraterone and its metabolites in real-world patients with metastatic castration-resistant prostate cancer

Source: Prostate Cancer and Prostatic Diseases - October 13, 2019 Category: Urology & Nephrology Authors: M. van Nuland S. L. Groenland A. M. Bergman N. Steeghs H. Rosing N. Venekamp A. D. R. Huitema J. H. Beijnen Source Type: research